Literature DB >> 1554871

Temporal relations of the endocrine response to hypotension with sodium nitroprusside.

R Ferrari1, C Ceconi, F De Giuli, A Panzali, P Harris.   

Abstract

Sodium nitroprusside was infused intravenously for 10 minutes in normal men, reclining at 45 degrees, in a dose sufficient to decrease the arterial pressure by 10 mmHg. The effect on a variety of plasma hormones was measured during the infusion and for 20 minutes afterwards. The heart rate increased to a maximum of 149%. Norepinephrine rose to a maximum of 196% in 5 minutes. Epinephrine reached a peak of 207% after 10 minutes. Plasma renin activity reached a peak of 449% at 10 minutes. Aldosterone did not change during the infusion, but increased to a maximum of 145% 10 minutes later. Vasopressin increased sharply at the end of the infusion to 893% and then rapidly decreased. Corticotropin, prolactin and growth hormone started to increase toward the end of the infusion, but reached their maxima during recovery. Corticotropin (225%) and prolactin (288%) peaked 10 minutes after the infusion, while growth hormone (414%) appeared still to be rising 20 minutes after the end of the infusion. Cortisol also rose progressively during recovery to a level of 138%. No significant changes were seen in the concentrations of insulin, glucagon, atrial natriuretic peptide, bombesin or neurotensin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554871

Source DB:  PubMed          Journal:  Cardioscience        ISSN: 1015-5007


  3 in total

Review 1.  Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process?

Authors:  R Ferrari; C Ceconi; S Curello; F Ferrari; R Confortini; P Pepi; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 2.  Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Authors:  R Ferrari; C Ceconi; S Curello; P Pepi; A Mazzoletti; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 3.  The problem of defining heart failure.

Authors:  P Harris
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.